Genprex Statistics
NASDAQ: GNPXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.69-0.06 (-2.18%)
Market open · Delayed 15 min · as of Oct 9, 3:18 PM ET
Genprex by the numbers
Genprex has a market capitalization of $2.2 million based on 819.71K shares outstanding. With trailing EPS of $-9.35, Genprex is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.1% below its 50-day average and 88.7% below its 200-day average.
Average daily trading volume is 247.06K shares, or about $664,578 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GNPX valuation vs. peer median
| Metric | GNPX | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.21M | $2.40M | -8% |
| Avg. volume | 247.06K | 489.59K | -50% |
Peer median across 8 companies: PPBT, TCRT, OGEN, ELAB, SPRC, XRTX, LABT, KAPA.
Valuation
- Market cap
- $2.21M
- EPS (TTM)
- $-9.35
- Shares outstanding
- 819.71K
Price and trading
- Previous close
- 2.75
- Open
- 2.81
- Day range
- 2.65 – 2.93
- 52-week range
- 2.53 – 1,210.00
- Beta
- —
- Volume
- 174.56K
- Average volume
- 247.06K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 7, 2025
Additional statistics
- Market Cap
- 2.21M
- Forward Pe
- -1.23
- Eps
- -9.35
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1,210.00
- Week52 Low
- 2.53
- Avg Volume
- 247.06K
- Shares Outstanding
- 819.71K
- Ma50
- 3.74
- Ma200
- 23.80
- Earnings Date
- Aug 7, 2025
- Pct From52w High
- -99.78%
- Pct From52w Low
- 6.32%